MRC2 and soft tissue sarcoma: uPARAP overexpression has also been observed in mesenchymal-like cancer tissues, including glioblastoma multiforme (14), osteosarcoma (15), soft tissue sarcomas (16), as well as in basal-like breast cancer (17).